The Beauty Health Company

NasdaqCM:SKIN Stock Report

Market Cap: US$138.9m

Beauty Health Future Growth

Future criteria checks 3/6

Beauty Health is forecast to grow earnings and revenue by 91% and 7.9% per annum respectively while EPS is expected to grow by 108.6% per annum.

Key information

91.0%

Earnings growth rate

108.6%

EPS growth rate

Personal Products earnings growth23.6%
Revenue growth rate7.9%
Future return on equityn/a
Analyst coverage

Good

Last updated12 Aug 2024

Recent future growth updates

Recent updates

Positive Sentiment Still Eludes The Beauty Health Company (NASDAQ:SKIN) Following 33% Share Price Slump

Aug 06
Positive Sentiment Still Eludes The Beauty Health Company (NASDAQ:SKIN) Following 33% Share Price Slump

Is There Now An Opportunity In The Beauty Health Company (NASDAQ:SKIN)?

Jul 16
Is There Now An Opportunity In The Beauty Health Company (NASDAQ:SKIN)?

Not Many Are Piling Into The Beauty Health Company (NASDAQ:SKIN) Stock Yet As It Plummets 28%

Jun 14
Not Many Are Piling Into The Beauty Health Company (NASDAQ:SKIN) Stock Yet As It Plummets 28%

Calculating The Fair Value Of The Beauty Health Company (NASDAQ:SKIN)

May 30
Calculating The Fair Value Of The Beauty Health Company (NASDAQ:SKIN)

The Beauty Health Company (NASDAQ:SKIN) Stock Rockets 31% But Many Are Still Ignoring The Company

Feb 16
The Beauty Health Company (NASDAQ:SKIN) Stock Rockets 31% But Many Are Still Ignoring The Company

The Beauty Health Company's (NASDAQ:SKIN) Share Price Matching Investor Opinion

Jun 19
The Beauty Health Company's (NASDAQ:SKIN) Share Price Matching Investor Opinion

Is The Beauty Health Company (NASDAQ:SKIN) Trading At A 39% Discount?

May 28
Is The Beauty Health Company (NASDAQ:SKIN) Trading At A 39% Discount?

At US$13.26, Is The Beauty Health Company (NASDAQ:SKIN) Worth Looking At Closely?

Apr 04
At US$13.26, Is The Beauty Health Company (NASDAQ:SKIN) Worth Looking At Closely?

Beauty Health's (NASDAQ:SKIN) Earnings Are Of Questionable Quality

Mar 08
Beauty Health's (NASDAQ:SKIN) Earnings Are Of Questionable Quality

What Is The Beauty Health Company's (NASDAQ:SKIN) Share Price Doing?

Jan 01
What Is The Beauty Health Company's (NASDAQ:SKIN) Share Price Doing?

An Intrinsic Calculation For The Beauty Health Company (NASDAQ:SKIN) Suggests It's 24% Undervalued

Dec 05
An Intrinsic Calculation For The Beauty Health Company (NASDAQ:SKIN) Suggests It's 24% Undervalued

The Beauty Health Company: A Compelling Mid To Long-Term Growth Story

Oct 12

Beauty-Health Company announces $200M buyback program

Sep 27

The Beauty Health Q2 2022 Earnings Preview

Aug 08

The Beauty Health Company: Not Looking The Best

Jul 30

Beauty Health: Skincare Today And Alpha Tomorrow

May 13

Results: The Beauty Health Company Exceeded Expectations And The Consensus Has Updated Its Estimates

May 12
Results: The Beauty Health Company Exceeded Expectations And The Consensus Has Updated Its Estimates

Calculating The Intrinsic Value Of The Beauty Health Company (NASDAQ:SKIN)

Apr 22
Calculating The Intrinsic Value Of The Beauty Health Company (NASDAQ:SKIN)

Earnings and Revenue Growth Forecasts

NasdaqCM:SKIN - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202643528-11-185
12/31/2025392-6152212
12/31/2024362-12-29-2412
6/30/2024366-84-82N/A
3/31/2024393-81618N/A
12/31/2023398-100-1022N/A
9/30/2023399-84-1122N/A
6/30/2023391-10-63-28N/A
3/31/2023377-7-118-81N/A
12/31/202236644-125-107N/A
9/30/202234620-123-98N/A
6/30/2022325-195-85-66N/A
3/31/2022288-340-86-68N/A
12/31/2021260-379-44-28N/A
9/30/2021220-365-40-32N/A
6/30/2021186-152-40-33N/A
3/31/2021134-23N/AN/AN/A
12/31/2020119-29-16-12N/A
9/30/2020131-19-12-3N/A
12/31/2019167-2-92N/A
12/31/2018112-91-9-1N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: SKIN is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.5%).

Earnings vs Market: SKIN is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: SKIN is expected to become profitable in the next 3 years.

Revenue vs Market: SKIN's revenue (7.9% per year) is forecast to grow slower than the US market (8.6% per year).

High Growth Revenue: SKIN's revenue (7.9% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if SKIN's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.